Prevalence of BRCA2 and CDKN2a mutations in German familial pancreatic cancer families

By Slater Emily   Langer Peter   Fendrich Volker   Habbe Nils   Chaloupka Brunhilde   Matthäi Elvira   Sina Mercedes   Hahn Stephan   Bartsch Detlef  

Familial Cancer, Vol. 9, Iss. 3, 2010-09 ,pp. : 335-343

Springer Publishing Company

Access to resources Recommend Favorite

Two new CHEK2 germ-line variants detected in breast cancer/sarcoma families negative for BRCA1 , BRCA2 , and TP53 gene mutations

By Manoukian Siranoush  

Breast Cancer Research and Treatment, Vol. 130, Iss. 1, 2011-11 ,pp. : 207-215

Springer Publishing Company

Access to resources Recommend Favorite

High-risk human papilloma virus infection, tumor pathophenotypes, and BRCA1/2 and TP53 status in juvenile breast cancer

By Aceto Gitana  

Breast Cancer Research and Treatment, Vol. 122, Iss. 3, 2010-08 ,pp. : 671-683

Springer Publishing Company

Access to resources Recommend Favorite

BRCA1 and BRCA2 in breast cancer

By Yang X.   Lippman M.E.  

Breast Cancer Research and Treatment, Vol. 54, Iss. 1, 1999-03 ,pp. : 1-10

Springer Publishing Company

Access to resources Recommend Favorite

p53 Inactivation is a Rare Event in Familial Breast Tumors Negative for BRCA1 and BRCA2 Mutations

By Sensi Elisa   Tancredi Mariella   Aretini Paolo   Cipollini Giovanna   Naccarato A. Giuseppe   Viacava Paolo   Bevilacqua Generoso   Caligo Maria A.  

Breast Cancer Research and Treatment, Vol. 82, Iss. 1, 2003-01 ,pp. : 1-9

Springer Publishing Company

Access to resources Recommend Favorite